ANNOUNCEMENT 31 May 2013

In May 2013, the government of Brazil announced a change in import duties.

NUMBER OF INTERVENTIONS

1

  • 0 harmful
  • 0 neutral
  • 1 liberalising

SOURCE



Camex resolution no. 37/13 of 29 May 2013 (in Portuguese): http://www.in.gov.br/visualiza/index.jsp?data=31/05/2013&jornal=1&pagina=3&totalArquivos=160
Camex press release of 31 May 2013 (in Portuguese): http://www.camex.gov.br/noticias/ler/item/322


Brazilian Foreign Trade Council. Câmara de Comércio Exterior. Resolução 82, de 25 de Outubro de 2018. Available at: http://www.camex.gov.br/component/content/article/62-resolucoes-da-camex/em-vigor/2128-resolucao-n-82-de-25-de-outubro-de-2018

Inception date: 31 May 2013 | Removal date: 25 Oct 2018
Still in force

Import tariff

On 31 May 2013, the Brazilian Foreign Trade Council (Camex) published resolution no. 37/13 reducing import tariffs on seven drugs. The items have been labeled as non-tariff products ('ex-tarifários') and added to the Mercosur List of Exceptions to the Common External Tariff (Letec). The goal is to reduce the costs for the public health care system SUS (Sistema Único de Saúde).
 
The measure came into effect on 31 May 2013 and affects the following drugs:
1. Abatacept (NCM 3002.10.29), reduced from 2% - 0%
2. Cetolizumab pegol (NCM 3002.10.29), reduced from 2% - 0%
3. Golimumab (NCM 3002.10.29) , reduced from 2% - 0%
4. Telaprevir (NCM 3004.90.69, already on Letec) reduce from 8%-0%
5. Boceprevir (NCM 3004.90.79, already on Letec) reduce from 8%-0%
6. Palivizumab (NCM 3002.10.39, already on Letec) reduced from 2% - 0%
7. Hemoderivatives factor VIII (NCM 3002.10.39), reduced from 2% - 0%

Update
On 25 October 2018, the Brazilian Foreign Trade Council has adopted Resolution 82 revoking 124 resolutions including this one.

AFFECTED SECTORS

 

AFFECTED PRODUCTS